AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

Gentamicin Sulphate Equivalent To

10 registrations across 1 African market— 5 active

Markets with Gentamicin Sulphate Equivalent To

Recent registrations

Brand / ProductMarketHolderStatusExpires
GENTAMYCIN-FRESENIUS 80 mg/2 ml (VIALS)🇿🇦South AfricaFresenius Kabi Manufacturing SA (Pty) LtdsuspendedJun 2025
GENTAMYCIN-FRESENIUS 20 mg/2 ml (VIALS)🇿🇦South AfricaFresenius Kabi Manufacturing SA (Pty) LtdsuspendedJun 2025
SEPTOPAL BEADS & CHAINS🇿🇦South AfricaMC Pharma (Pty) LtdsuspendedFeb 2023
BEECHAM GENTAMICIN AMPOULES 80 mg/2 ml🇿🇦South AfricaPharmaco Distribution (Pty) LtdsuspendedJun 2022
GENTAMIX INJECTION🇿🇦South AfricaAdcock Ingram LimitedsuspendedFeb 2022
INTRAMED FERMENTMYCIN INFUSION🇿🇦South AfricaBODENE (PTY) LTD TRADING AS INTRAMEDactiveJan 1900
GENTAMYCIN 20 mg/2 ml (AMPOULES) FRESENIUS🇿🇦South AfricaFresenius Kabi Manufacturing SA (Pty) LtdactiveJan 1900
GENTAMYCIN 40 mg/1 ml (AMPOULES) FRESENIUS🇿🇦South AfricaFresenius Kabi Manufacturing SA (Pty) LtdactiveJan 1900
GENTAMYCIN 80 mg/2 ml (AMPOULES) FRESENIUS🇿🇦South AfricaFresenius Kabi Manufacturing SA (Pty) LtdactiveJan 1900
GENTAMICIN 80 mg/2 ml UNIMED🇿🇦South AfricaUnimed Healthcare (Pty) LtdactiveJan 1900

Gentamicin Sulphate Equivalent To in Africa — Regulatory Overview

Gentamicin Sulphate Equivalent To is registered across 1 African markets with 10 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa. AfricaRegulatory refreshes this data daily from official government sources.

Of the 10 registrations, 5 (50%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.